Extracted from this filing and checked against the source text.
Material Agreements
SEC 8-K Item 1.01/1.02
confidence 0.9
Annovis Bio, Inc. entered into Underwriting Agreement with Canaccord Genuity LLC valued at Combined offering price of $1.90 per Share and accompanying Warrant, gross proceeds ~$10 million (effective 2026-04-09).
- Action
- entry
- Agreement
- underwriting
- Counterparty
- Canaccord Genuity LLC
- Value
- Combined offering price of $1.90 per Share and accompanying Warrant, gross proceeds ~$10 million
- Effective
- 2026-04-09
Exact text from the filing
On April 9, 2026, Annovis Bio, Inc. (the “Company”) entered into (i) an Underwriting Agreement (the “Underwriting Agreement”), dated as of April 9, 2026, with Canaccord Genuity LLC, as underwriter (the “Underwriter”), pursuant to which the Company agreed to issue and sell, in an underwritten registered direct offering (the “Offering”) (i) an aggregate of 5,263,156 shares of common stock (the “Shares”), $0.0001 par value per share (the “Common Stock”), of the Company and (ii) accompanying common stock warrants to purchase an aggregate of 5,263,156 shares of Common Stock (the “Warrants” and the shares of Common Stock issuable upon exercise of the Warrants, the “Warrant Shares”).
View on SEC.gov